Head and Neck Cancer A Brief Review of 852 Patients Treated in Kurume University Hospital During the 10 years from 1971 to 1980
|
|
- Allyson Sanders
- 5 years ago
- Views:
Transcription
1 THE KURUME MEDICAL JOURNAL Vol. 29, Supplement, P. S1- S7, 1982 Head and Neck Cancer A Brief Review of 852 Patients Treated in Kurume University Hospital During the 10 years from 1971 to 1980 MINORU HIRANO Department of Otolaryngology, Kurume University School of Medicine, Kurume, 830 Japan Received for publication April 10, 1982 Summary: During the 10 years from 1971 to 1980, 852 patients of histologically proven head and neck cancer were treated at our inpatient clinic. The most frequent pathology was carcinoma of the larynx, being followed by carcinomas of the maxillary sinus and the oral cavity. The 5-year survival rate was high for carcinomas of the thyroid gland (76.8%), larynx (69.4%), tongue (61.4%) and nasal cavity (60%). It was low for carcinomas of the epipharynx (17.8%) and hypopharynx and cervical esophagus (25.4%). Key words: cancer head and neck head and neck cancer survival rate causes of death Introduction During the 10 years from 1971 to 1980, 852 patients of histologically proven head and neck cancer were treated at the inpatient clinic of the Department of Otolaryngology, Kurume University Hospital. This paper presents a brief status report on these patients. Details of each group of patients will be reported in the following articles in this booklet. Distribution of the Patients 1.Distribution by nature and site of lesion Table 1 presents distribution of the 852 patients by nature and site of the lesion. Right hundred patients were not previously treated whereas 52 patients were previously treated cases. Of the former 800, 726 patients underwent curative treatments while 74 were palliatively treated for various reasons, and, in the latter 52, 43 received curative treatments, while 9 had palliative treatments. Carcinoma of the larynx was the most frequent pathology (260/852, 30.5%), carcinoma of the maxillary sinus was the second most frequent (124/852, 14.6%), and carcinoma of the oral cavity was the third (110/852, 12.9%). Neoplasmas of epithelial origin were much more frequent than those of non-epithelial origin. 2.Distribution by staging Tables 2-5 present distribution of the patients of major groups of carcinoma by TNM classification and stage grouping. Those patients who had been previously treated before their admission to our hospital are excluded from these tables. With respect to T category, early cases were found most frequently for the larynx, then for the oral cavity, oropharynx, salivary glands and thyroid gland. On the other hand, advanced cases were frequent for the maxillary sinus, nasal cavity, naso- S1
2 TABLE1 Head and neck cancer Histologically Proven cases treated at Kurume University Hospital during 10 Years from 1971 to 1980.
3 HEAD AND NECK CANCER S3 pharynx, hypopharynx and cervical esophagus (Table 2). As regards neck metastasis, carcinoma of the nasopharynx presented the worst figure. Almost all patients of this group had clinically positive lymphonodes. Positive nodes were frequently palpated also for carcinoma of the oropharynx, hypopharynx and cervical esophagus. On the contrary, cervical metastasis was infrequent for carcinoma of the nasal cavity, maxillary sinus, lip and larynx (Table 3). Distant metastasis was rare in all groups as shown in Table 4. As to stage grouping, advanced stages were the most frequent for carcinoma of the epipharynx. All the cases of this pa thology were Stage III or IV. Cases of ad- TABLE 2 Distribution of patients by site and T category T classification is based on UICC classification (UICC, 1978) cxcept for the nasal cavity, maxillary sinus and major salivary gland. For the nasall cavity and maxillary sinus, Sakai classification (Sakai, 1970) is applied whereas AJC classification (AJC, 1977) is used for major salivary gland. TABLE 3 Distribution of patients by site and N category N classification is based on UICC classification (UICC, 1978).
4 S4 HIRANO vanced stages were also frequent for the nasal cavity, maxillary sinus, lip, oropharynx, hypopharynx and cervical esophagus (Table 5). Carcinomas of the salivary and thyroid glands are not included in Table 5 because no stage grouping has been re commended yet. TABLE 4 Distribution of patients by site and M category Results of Treatments 1.Five-year survival rate Table 6 compares the 5-year survival rate for different groups of cancer. Those groups which had a small number of pa tients are excluded. The 5-year survival rate was calculated by the actuarial method for the patients who had not been previ ously treated and underwent curative treat ments in our hospital. Therefore, those patients who had been previously treated in other hospitals and those patients who were palliatively treated are not included M classification is based on UICC classifi cation (UICC, 1978). TABLE 5 Distribution of patients by site and stage Stage grouping is based on UICC classification (UICC, 1978) except for the nasal cavity and maxillary sinus. For the nasal cavity and maxillary sinus, Sakai classification (Sakai, 1970) is applied. * Five Tis cases are excluded. ** One case of Hodgkin lymphoma is not included.
5 HEAD AND NECK CANCER S5 in this calculation. The 5-year survival rate was the greatest for carcinoma of the thyroid gland, especially for differentiated carcinoma. For the remainings, the survival rate became smaller in the order of the larynx tongue, nasal cavity, salivary glands, maxillary sinus, lymphoma, oropharynx, hypophar ynx and cervical esophagus, and naso pharynx. Fig.1 presents the relationship between the rate of the occurrence of Stage N and the 5-year survival rate. There was a tendency that the greater the rate of Stage N patients was the smaller the survival rate. Stage N cases were minimum for carcino mas of the tongue and larynx and the sur vival rate was high for them, whereas the survival rate was minimum for carcinoma of the nasopharynx which included many Stage N cases. Fig.2 shows the relationship between the rate of the occurrence of Stages III and N and the survival rate. In this figure, there was an obvious separation of the car cinomas investigated into two groups. The first group consisted of carcinomas of the TABLE 6 Five-year survival rate in her cent calcu lated by the actuarial method larynx, tongue, nasal cavity and maxillary sinus, presenting high survival rates. The second group consisted of carcinomas of the epipharynx, oropharynx, hypopharynx and cervical esophagus, showing low sur vival rate. Within each of the two groups, there was a tendency that the greater the rate of the occurrence of Stage III and N was the lower the survival rate. The results shown in Fig.1 and 2 in- Fig.1. Relationship between rate of occurrence of Stage IV and 5-year survival rate * Values for differentiated carcinoma ** Non-Hodgkin lymphoma Fig.2. Relationship between rate of occurrence of Stages III and IV and 5-year survival rate
6 S6 HTRANO dicate that Stage III cases of carcinomas of the larynx, tongue, nasal cavity and maxillary sinus can be more successfully treated than those of carcinomas of the pharynx and the cervical esophagus. 2.Cause of death Table 7 shows the cause of death for different major groups of cancer. Only those patients who had not been previously treated and underwent curative treatments were included in this study, excluding those patients who had been previously treated or who received only palliative treatments. The cause of death were classified as follows: (1) Death from the tumor present (a) Death from primary lesion (T). Pa tients who died with primary lesion un controlled with or without neck and/or distant metastasis were classified into this category. (b) Death from neck metastasis (N). Patients who died with neck metastasis uncontrolled, with primary lesion controlled with or without distant metastasis were classified into this category. (c) Death from distant metastasis (M). Patients who died with distant metastasis with primary and neck controlled were classified into this category. (d) Surgical death. Patients who died within 30 days after major surgical treat ment were classified into this category. (e) Death from complication. Patients who died of complication caused by any therapeutic intervention were classified into this category. Surgical death is one kind of death resulting from complications. In this paper, surgical death is described se parately from those occuring from other complications. (f) Unknown. Dead patients of whom no information about the cause of death was available were classified into this ca tegory. (2) Death from intercurrent disease. Patients who died of intercurrent disease and had no evidence of the carcinoma pre sent were classified into this category. This definition is primarily based on the proposal by the Japan Society of Head and Neck Tumor (1981). The deaths from pri mary, neck metastasis and distant metas tasis were defined according to Hirano et al. (1976). Failures to control the primary lesion was a frequent cause of death for carcino mas of the nasopharynx, major salivary TABLE 7 Cause of death for curative treatment group Number in parenheses indicates per cent.
7 HEAD AND NECK CANCER S7 glands, and maxillary sinus. It was rare for carcinoma of the larynx. As regards cervical metastasis, failures in managing was a significant cause of death for car cinoma of the tongue, oropharynx, hypo pharynx and cervical esophagus. Distant metastasis was the cause of death in one fifth or more of the deaths for carcinomas of the oropharynx, hypopharynx and cer vical esophagus, larynx and salivary glands. It should be noted that surgical or other complications were a significant cause of death for carcinoma of the hypopharynx and cervical esophagus. For carcinoma of the larynx, more than half of the entire deaths resulted from intercurrent diseases. Coments It appears that early diagnosis of car cinomas of the nasal cavity, maxillary sinus, nasopharynx, oropharynx, hypopharynx and cervical esophagus is not frequently made. In particular, this accounts for the poor prognosis of carcinomas of the phar ynx and esophagus. A campaign for early diagnosis of these diseases may be de manded. Also, further effort should be made to improve treatment methods of these pathologies. Regardless of a high incidence of ad vanced cases, carcinomas of the nasal cavity and maxillary sinus presented with a fairly high survival rate. This can be attributed to a poor lymphatic flow from these sites and to the recent advancement of combined therapies. In the present review, carcinomas of the thyroid gland, larynx, tongue, nasal cavity, major salivary glands, and maxil lary sinus presented with a favorable prog nosis whereas those of the nasopharynx, hypopharynx and esophagus, and orophar ynx demonstrated a poor prognosis. Malig nant lymphoma was in between these two groups. For carcinomas of the larynx and tongue, the post-therapeutic function should be an important issue. Early detection of these pathologies is desired chiefly for a favorable functional result. Futher developments of reconstructive modalities are demanded for advanced cases of these diseases. References American Joint Committee for Cancer Staging and End-Results Reporting (AJC) (1977). Manual for staging of cancer. HIRANO, M., SHIN, T., MIHASHI, S., ICHIKAWA, A., MIHASHI, K. and HIROTO, I. (1976). Long term results of treatments for carcinoma of the larynx. Otologia (Fukuoka). 22, Japan Society of Head and Neck Tumor (1981). Unpublished report. SAKAI, S. (197). A proposal for TNM classifi cation of malignant neoplasms of the head and neck which are not classified at UICC. Unpublished report. UICC (1978). TNM Classification of Malignant Tumors. Geneva.
Carcinoma of the Hypopharynx and Cervical Esophagus. Department of Otolaryngology, Kurume University School of Medicine, Kurume, 830 Japan
THE KURUME MEDICAL JOURNAL Vol. 29, Supplement, P. S97-S111, 1982 Carcinoma of the Hypopharynx and Cervical Esophagus A Retrospective Investigation of 67 Patients MINORU HIRANO, SHIGEJIRO KURITA, KOHJI
More informationCarcinoma of the Lip and Oral Cavity -A Retrospective Investigation of 113 Patients
THE KURUME MEDICAL JOURNAL Vol. 29, Supplement, P. S61-S78, 1982 Carcinoma of the Lip and Oral Cavity -A Retrospective Investigation of 113 Patients HIROSHI OHKUBO, TATSUO MAEDA, MINORU HIRANO, SHIGEJIRO
More informationCancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
More informationPhysician to Physician AJCC 8 th Edition. Head and Neck. Summary of Changes. AJCC Cancer Staging Manual, 7 th Ed. Head and Neck Chapters
Physician to Physician Head and Neck William M. Lydiatt, MD Chair of Surgery Nebraska Methodist Hospital Clinical Professor of Surgery, Creighton University Validating science. Improving patient care.
More informationKatsuro Sato. Department of Speech, Language and Hearing Sciences, Niigata University of Health and Welfare, Niigata, Japan
Report Niigata Journal of Health and Welfare Vol. 12, No. 1 Retrospective analysis of head and neck cancer cases from the database of the Niigata Prefecture Head and Neck Malignant Tumor Registration Committee
More informationDepartment of Otolaryngology, Kurume University School of Medicine, Kurume, Japan
THE KURUME MEDICAL JOURNAL Vol. 16, No. 3, 1969 PATHOLOGICAL STUDIES RELATING TO NEOPLASMS OF THE HYPOPHARYNX AND THE CERVICAL ESOPHAGUS IKUICHIRO HIROTO, YASUSHI NOMURA, KUSUO SUEYOSHI, SHIGENOBU MITSUHASHI,
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationManagement guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007
Management guideline for patients with differentiated thyroid Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Incidence (Srinagarind Hospital, 2005, both sex) Site (all) cases % 1. Liver 1178 27 2. Lung
More informationRADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.
RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1. 550 000 NEW PATIENTS/YEAR WITH HEAD AND NECK CANCER ALL
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationHiroyuki Hanakawa, Nobuya Monden, Kaori Hashimoto, Aiko Oka, Isao Nozaki, Norihiro Teramoto, Susumu Kawamura
Accepted Manuscript Radiation-induced laryngeal angiosarcoma: Case report Hiroyuki Hanakawa, Nobuya Monden, Kaori Hashimoto, Aiko Oka, Isao Nozaki, Norihiro Teramoto, Susumu Kawamura PII: S2468-5488(18)30005-5
More information6 th Reprint Handbook Pages AJCC 7 th Edition
6 th Reprint Handbook Pages AJCC 7 th Edition AJCC 7 th Edition Errata for 6 th Reprint Table 1 Handbook No Significant Staging Clarifications for 6 th Reprint AJCC 7 th Edition Errata for 6 th Reprint
More informationCarcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY
Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY SEARCHING FOR THE PRIMARY? P r o f J P P r e t o r i u s H e a d : C l i n i c a l U n i t C r i t i c a l C a r e U n i v e r s i t y O f
More informationAJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-
TX: primary tumor cannot be assessed T0: no evidence of primary tumor Tis: carcinoma in situ. T1: tumor is 2 cm or smaller AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY- T2:
More informationT h r o a t c a n c e r i 1 0
T h r o a t c a n c e r i 1 0 Have you or a loved one been diagnosed with Liver Cancer? Read this overview of 11 effective, natural strategies to fight back and defeat this deadly disease. 10-3-2018 Aphagia
More informationGreater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute
2008 ANNUAL REPORT Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute Cancer Registry Report The Cancer Data Management System/ Cancer Registry collects data on all types of cancer
More informationHead and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.
Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S. Associate Professor Division of Head and Neck Surgery Department of Otolaryngology-Head and
More informationEvaluation and Treatment of Dysphagia in the Head and Neck Cancer Patient
Evaluation and Treatment of Dysphagia in the Head and Neck Cancer Patient Linda Stachowiak MS/CCCSLP BCS-S Speech Pathology Oncology Specialist UFHealth Cancer Center at Orlando Health Orlando Florida
More informationANTIBODY TO EPSTEIN-BARR VIRUS IN PATIENTS WITH CARCINOMA OF THE NASOPHARYNX
Keio J. Med. 26: 79-90, 1977 ANTIBODY TO EPSTEIN-BARR VIRUS IN PATIENTS WITH CARCINOMA OF THE NASOPHARYNX YUKIO INUYAMA*, KAZUYUKI ASAOKA*, YASUO NAKAJIMA*, MASATOSHI HORIUCHI*, KEI TAKASAKI** and RAISUKE
More informationAnne Marie Brown Macmillan Head & Neck CNS
Advances in the Treatment of Head & Neck cancer Anne Marie Brown Macmillan Head & Neck CNS Aims To provide a brief revision of Head & Neck anatomy and background statistics To demonstrate the processes
More informationAJCC Cancer Staging 8 th edition. Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx
AJCC Cancer Staging 8 th edition Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx AJCC 7 th edition Lip and Oral cavity Pharynx Larynx KEY CHANGES Skin of head and neck (Vermilion of the lip)
More informationNCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)
BONE (Version 2.2018, 03/28/18) NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) Radiation Therapy Specialized techniques such as intensity-modulated RT (IMRT); particle beam RT with protons, carbon ions,
More informationRadiation Oncology Study Guide
Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire
More informationEvaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S.
Evaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S. Residency Site Director Weill Cornell Medical Center Associate Professor Division of Head
More informationWhat is ACC? (Adenoid Cystic Carcinoma)
What is ACC? (Adenoid Cystic Carcinoma) 10-9-10 Where ACC Occurs ACC (Adenoid Cystic Carcinoma) is a rare and unique form of cancer that is known to be unpredictable in nature, with a typical growth pattern
More informationOral Cancer Risk and Detection
Oral Cancer Risk and Detection Evan M. Graboyes, MD Assistant Professor Department of Otolaryngology-Head & Neck Surgery Cancer Control Program, Hollings Cancer Center Medical University of South Carolina
More informationClinico-pathological Evaluation of Cervical Lymph Node Metastasis of Tongue Squamous Cell Carcinoma Keywords :
29 2 14 4 Clinico-pathological Evaluation of Cervical Lymph Node Metastasis of Tongue Squamous Cell Carcinoma Yasuhiko Tsuyama, Takashi Nakatsuka, Yoshiyuki Mori, Tsuyoshi Takato (Department of Plastic
More informationCancer survival in Hong Kong SAR, China,
Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.
More informationHead & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i
Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate Head & Neck Clinical Sub Group Network Agreed Imaging Guidelines for UAT and Thyroid Cancer Measure Nos: 11-1C-105i &
More informationReport of Head and Neck Cancer Registry of Japan. Clinical Statistics of Registered Patients, 2002
Report of Head and Neck Cancer Registry of Japan Clinical Statistics of Registered Patients, Japan Society for Head and Neck Cancer Cancer Registry Committee Preface The Head and Neck Cancer Registry of
More informationANALYSIS OF SECONDARY NECK NODES IN MALIGNANCIES OF UPPER AERODIGESTIVE TRACT
CIBTech Journal of Surgery ISSN: 39-3875 (Online) 03 Vol. () May-August, pp.-6/renukananda et al. ANALYSIS OF SECONDARY NECK NODES IN MALIGNANCIES OF UPPER AERODIGESTIVE TRACT Renukananda G.S., Santosh
More informationHead & Neck Staging. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging
AJCC 8 th Edition Staging Head & Neck Staging Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
More informationAJCC 8 th Edition Staging. Head & Neck Staging. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.
AJCC 8 th Edition Staging Head & Neck Staging Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
More informationLYMPHATIC DRAINAGE IN THE HEAD & NECK
LYMPHATIC DRAINAGE IN THE HEAD & NECK Like other parts of the body, the head and neck contains lymph nodes (commonly called glands). Which form part of the overall Lymphatic Drainage system of the body.
More informationOral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi
Oral cancer: Prognosis & Treatment Dr. Hani Al Sheikh Radhi Prognostic factors in Oral caner TNM staging T stage N stage M stage Site Histological Factors Vascular & Perineural Invasion Surgical Margins
More informationAppendix 1: QIICR Iowa Head and Neck Clinical Data DICOM SR Template
Appendix 1: QIICR Iowa Head and Neck Clinical Data DICOM SR Template Table of Content s Document Histor y TID QIICR_2000. Clinical Data Repor t TID QIICR_2002. Biops y TID QIICR_2003. Surgical Procedure
More informationRola brachyterapii w leczeniu wznów nowotworów języka i dna jamy ustnej. The role of brachytherapy in recurrent. oral cavity
Rola brachyterapii w leczeniu wznów nowotworów języka i dna jamy ustnej The role of brachytherapy in recurrent tumours of the tongue and fundus of the oral cavity Janusz Skowronek, MD, PhD, Ass. Prof.
More informationHead and Neck Squamous Subtypes
1 Head and Neck Squamous Subtypes Adel K. El-Naggar, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, Texas HNSCC 5 th -6 th most common cancer 400,000/year 50% mortality Considerable
More informationVolumi di trattamento del cavo orale
SIMPOSIO: Neoplasie del cavo orale Volumi di trattamento del cavo orale F. Miccichè ! DICHIARAZIONE Relatore: Francesco Miccichè Come da nuova regolamentazione della Commissione Nazionale per la Formazione
More informationSITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR
SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR Anus: Anal Canal; Anus, NOS; Other Parts of Rectum C21.0-C21.2, C21.8 C21.0 Anus, NOS (excludes skin of anus and perianal skin C44.5) C21.1 Anal canal C21.2
More informationCLINICAL MEDICATION POLICY
CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals
More informationCANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
More information4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.
Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:
More informationIntensity Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) Policy Number: Original Effective Date: MM.05.006 03/09/2004 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 05/01/2017 Section: Radiology
More informationCorporate Medical Policy
Corporate Medical Policy Intensity Modulated Radiation Therapy (IMRT) of Head and Neck File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_head_and_neck
More informationCancer survival in Seoul, Republic of Korea,
Cancer survival in Seoul, Republic of Korea, 1993 1997 Ahn YO and Shin MH Abstract The Seoul cancer registry was established in 1991. Cancer is a notifiable disease, and registration of cases is done by
More informationJochen A. Werner R. Kim Davis (Eds.) Metastases in Head and Neck Cancer
Jochen A. Werner R. Kim Davis (Eds.) Metastases in Head and Neck Cancer Jochen A. Werner R. Kim Davis (Eds.) Metastases in Head and Neck Cancer With 106 Figures and 21 Tables 123 ISBN 3-540-20507-1 Springer
More informationProtons for Head and Neck Cancer. William M Mendenhall, M.D.
Protons for Head and Neck Cancer William M Mendenhall, M.D. Protons for Head and Neck Cancer Potential Advantages: Reduce late complications via more conformal dose distributions Likely to be the major
More informationNational Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2)
National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: 13-14 (V2) Produced as part of the Cancer Research UK - Public Health
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationNICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36
Cancer of the upper aerodigestive e tract: assessment and management in people aged 16 and over NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36 NICE 2018. All rights reserved. Subject
More informationCancer survival in Busan, Republic of Korea,
Cancer survival in Busan, Republic of Korea, 1996 2001 Shin HR, Lee DH, Lee SY, Lee JT, Park HK, Rha SH, Whang IK, Jung KW, Won YJ and Kong HJ Abstract The Busan cancer registry was established in 1996;
More informationCODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser
CODING STAGE: TNM AND OTHER STAGING SYSTEMS Liesbet Van Eycken Otto Visser OVERVIEW PART I Introduction What is stage? Why stage? History and publications of TNM Classification Clinical and pathologic
More informationNasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. DULGUEROV, Pavel, et al.
Article Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review DULGUEROV, Pavel, et al. Abstract The authors reviewed treatment results in patients
More informationClinical Study Mucosal Melanoma in the Head and Neck Region: Different Clinical Features and Same Outcome to Cutaneous Melanoma
ISRN Dermatology Volume 2013, Article ID 586915, 5 pages http://dx.doi.org/10.1155/2013/586915 Clinical Study Mucosal Melanoma in the Head and Neck Region: Different Clinical Features and Same Outcome
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 2, March 2014
INCIDENCE OF PRIMARY HEAD AND NECK CANCERS AT B K L W HOSPITAL & RURAL MEDICAL COLLEGE, A TERTIARY CARE CENTRE IN KONKAN, MAHARASHTRA RAJASHREE A KULKARNI* MAHESH S PATIL** *Assistant Professor, Dept.
More informationAJCC Cancer Staging Form Supplement
AJCC Cancer Staging Form Supplement AJCC Cancer Staging Manual, Eighth Edition Last updated 05 June 2018 AMERICAN JOINT COMMITTEE ON CANCER Executive Office 633 North Saint Clair Street Chicago, IL 60611
More informationOverview of 2009 Hong Kong Cancer Statistics
Overview of 2009 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since 1963 been providing population-based cancer data for epidemiological research and healthcare
More information155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
More informationChapter 1 MAGNITUDE AND LEADING SITES OF CANCER
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Pharynx 12/6/12. NAACCR Webinar Series Collecting Cancer Data Pharynx
Collecting Cancer Data Pharynx NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationCancer survival in Shanghai, China,
Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely
More informationComprehensive Cancer Cover
Comprehensive Cancer Cover Tech Spec Comprehensive Cancer Cover provides the life insured with cover for the diagnosis and treatment of defined malignant tumours. These tumours must be characterised either
More informationManagement of unknown primary with neck node metastasis: Current evidence
Management of unknown primary with neck node metastasis: Current evidence Dr. Pooja Nandwani Patel Associate Professor Dept. of Radiation Oncology GCRI, Ahmedabad Introduction- Approach to Topic What is
More informationOSCaR UPDATE. Manager s Update Donald Shipley, MS. Oregon State Cancer Registry
Oregon State Cancer Registry OSCaR UPDATE VOLUME 8, QUARTER 4 W INTER 2008 Manager s Update Donald Shipley, MS Since the Fall issue of OSCaR Update, the registry staff has completed several significant
More informationHead and Neck Cancer How to recognize it in your office
Head and Neck Cancer How to recognize it in your office Peter M Hunt, MD, FACS Associates in ENT/Head & Neck Surgery Director CHI Memorial Head & Neck and Melanoma Centers of Excellence September 8, 2018
More informationIncidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States
Incidence of HPV-Associated Head and Neck Cancers by Sub-site Among Diverse Racial/Ethnic Populations in the United States Louisiana Tumor Registry LSUHSC School of Public Health Lauren Cole, MPH Linda
More informationPreface... Contributors... 1 Embryology... 3
Contents Preface... Contributors... vii xvii I. Pediatrics 1 Embryology... 3 Pearls... 3 Branchial Arch Derivatives... 3 Branchial Arch Anomalies: Cysts, Sinus, Fistulae... 4 Otologic Development... 4
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More informationCancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
More informationCOMMENTARY AJCC STAGE GROUPINGS FOR HEAD AND NECK CANCER: SHOULD WE LOOK AT ALTERNATIVES? A REPORT OF THE HEAD AND NECK SITES TASK FORCE
COMMENTARY AJCC STAGE GROUPINGS FOR HEAD AND NECK CANCER: SHOULD WE LOOK AT ALTERNATIVES? A REPORT OF THE HEAD AND NECK SITES TASK FORCE William M. Lydiatt, MD, 1 Jatin P. Shah, MD, 2 Henry T. Hoffman,
More informationThyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES
AJC 7/14/06 1:19 PM Page 67 Thyroid C73.9 Thyroid gland SUMMARY OF CHANGES Tumor staging (T) has been revised and the categories redefined. T4 is now divided into T4a and T4b. Nodal staging (N) has been
More information2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
More informationFig. 1 The method of making a free jejunal graft
Key words: reconstruction of cervical esophagus, free jejunal autograft, carcinoma of hypopharynx and cervical esophagus Fig. 1 The method of making a free jejunal graft Table I Cases of hypopharyngeal
More informationL ARYNX S TAGING F ORM
CLI N I CA L Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX T0 Tis a b L ARYNX S TAGING F ORM LATERALITY: TUMOR SIZE: left
More informationOropharyngeal cancer
Cancer Imaging (2005) 5, S52 S57 DOI: 10.1102/1470-7330.2005.0030 CI MULTIDISCIPLINARY SYMPOSIUM: HEAD & NECK CANCER Monday 3 October 2005, 14:00 16:00 Oropharyngeal cancer Robert Hermans Department of
More informationCANCER AND SURVIVAL RATE.
19 THE RELATION BETWEEN DELAY IN TREATMENT OF CANCER AND SURVIVAL RATE. W. L. HARNETT. From the British Empire Cancer Campaign, 11, Grosvenor Crescent, Hyde Park Corner, London, S. W. 1. Received for publication
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
More informationLearning objectives Describe anatomically and clinically the di ifference between laryngeal cancer and hypopharyngeal cancer Be able to describe clini
Laryngeal cancer Hanwei PENG, MD, PhD Thyroid Surgery Research Center, SU UMC Head and Neck Department, Cancer Hospital, SUMC Learning objectives Describe anatomically and clinically the di ifference between
More informationHead and Neck Tumours
Head and Neck Tumours Introductory Notes The following sites are included: Lip, oral cavity Pharynx: oropharynx, nasopharynx, hypopharynx Larynx: supraglottis, glottis, subglottis Nasal cavity and paranasal
More informationC. Douglas Phillips, MD FACR Director of Head and Neck Imaging Weill Cornell Medical Center NewYork Presbyterian Hospital
C. Douglas Phillips, MD FACR Director of Head and Neck Imaging Weill Cornell Medical Center NewYork Presbyterian Hospital Objectives Review basics of head and neck imaging Discuss our spatial approach
More information2. Guidelines for Reporting Head and Neck Tumours
39 40 2. Guidelines for Reporting Head and Neck Tumours Compilation and editing of this volume: Dr. Modini Jayawickrama (Consultant Histopathologist) List of contributors Consultant Histopathologists Dr.
More informationTrends in Cancer Survival in Scotland
Scottish Cancer Intelligence Unit Trends in Cancer Survival in Scotland - Trends in survival are presented for the half million adult cancer patients diagnosed in Scotland between and. The Results show,
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
More informationOverview of 2010 Hong Kong Cancer Statistics
Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research
More informationThe clinical utilization of radiation therapy in Korea between 2009 and 2013
Original Article Radiat Oncol J ;(): pissn eissn The clinical utilization of radiation therapy in Korea between and JinKyu Kang, MD, MiSook Kim, MD, PhD,, WonIl Jang, MD, Young Seok Seo, MD, Hee Jin Kim,
More informationIntroduction to ICD-O-3 coding rules
Introduction to ICD-O-3 coding rules Weena Laddachayaporn, MD National Cancer Institute, Bangkok, Thailand ICD-O-3 The International Classification of Diseases for Oncology Is a coding system for primary
More informationHistory of tonsillar cancer icd 10 code
Pesquisar... History of tonsillar cancer icd 10 code 30-9-2015 Free, official information about 2012 (and also 2013-2015) ICD -9-CM diagnosis code 146.0, including coding notes, detailed descriptions,
More informationSurvival in sinonasal and middle ear malignancies: a population-based study using the SEER database
Gore BMC Ear, Nose and Throat Disorders (2018) 18:13 https://doi.org/10.1186/s12901-018-0061-4 RESEARCH ARTICLE Open Access Survival in sinonasal and middle ear malignancies: a population-based study using
More informationLecture 07. Lymphatic's of Head & Neck. By: Dr Farooq Amanullah Khan PMC
Lecture 07 Lymphatic's of Head & Neck By: Dr Farooq Amanullah Khan PMC Dated: 28.11.2017 Lymphatic Vessels Of the 800 lymph nodes in the human body, 300 are in the Head & neck region. The lymphatic vessels
More informationQUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX
QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX MP/H Quiz 1. A patient presented with a prior history of squamous cell carcinoma of the base of the tongue. The malignancy was originally diagnosed
More informationFINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma
Case Scenario 1 HNP: A 70 year old white male presents with dysphagia. The patient is a current smoker, current user of alcohol and is HPV positive. A CT of the Neck showed mass in the left pyriform sinus.
More informationThe following images were all acquired using a CTI Biograph
Positron Emission Tomography/ Computed Tomography Imaging of Head and Neck Tumors: An Atlas Michael M. Graham, MD, PhD, and Yusuf Menda, MD Department of Radiology, University of Iowa, Iowa City, IA. Address
More informationHead and Neck Cancers Data Quality Report Radiotherapy and Chemotherapy Data
Head and Neck Cancers Data Quality Report Radiotherapy and Chemotherapy Data 1 This report has been compiled by Jinan Ridha, Analyst, Oxford Cancer Intelligence Unit (OCIU) With acknowledgements Mr Richard
More informationAll Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
More information2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018
1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington
More informationMicroscopically diagnosed head and neck cancers in the University Hospital, Kuala Lumpur
Med. J. Malaysia Vol. 44 No. 1 March 1989 Microscopically diagnosed head and neck cancers in the University Hospital, Kuala Lumpur Jayalakshmi P, MRCPath, Lecturer Pathmanathan R, MRCPath, Associate Professor
More informationSarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia
Case Report Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia Jagtap Sunil V. 1, Shukla Dhirajkumar B. 2, Jagtap Swati S. 3, Havle Abhay D. 4 1 Associate Professor, Department
More information